Home › Teva's Laquinimod MS Pill Fails to Win EU Agency's Backing
 

Keywords :   


Teva's Laquinimod MS Pill Fails to Win EU Agency's Backing

2014-01-25 14:58:18| Biotech - Topix.net

Teva Pharmaceutical Industries Ltd. failed to win backing from the European Union drug regulator for a new multiple sclerosis pill, hurting the company's effort to introduce a successor to its best-selling injection Copaxone.

Tags: win fails pill backing

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05New ACA-Published Industry Market Analysis for the Paint & Coatings Industry Now Available
20.05Ulta Beauty Launches Same-Day Delivery with DoorDash
20.05Nivea Crmes Limited-Edition Pride Tin Heralds New Initiative with PFLAG
20.05Sheboygan Paint Company Appoints New Technical Sales Representative
20.05Scentair Adds Two Odor-Neutralizing Fragrances to its Auto Line Up
20.05GK Hair Unveils Summer 2024s Must-Have Hair Trends
20.05Revlon Taps Under Armour\'s Tchernavia Rocker As New Chief People Officer
20.05Canada invests over $9.6M to prevent, prepare for African swine fever
More »